|
|
|
|
Laboratoire de Biologie Moléculaire et Cellulaire, Université de Bourgogne, Dijon, France (S.F., S.S., C.G., M.B.); Brain Research Institute (J.B., A.N.) and Institute of Neurology (B.M.), University of Vienna, Vienna, Austria; and Institut National de la Santé et de la Recherche Médicale U488, Le Kremlin-Bicêtre, France (F.C., M.E.E.)
X-linked adrenoleukodystrophy (X-ALD) is a demyelinating disorder
associated with impaired very-long-chain fatty-acid (VLCFA)
-oxidation
caused by mutations in the ABCD1 (ALD) gene that encodes a
peroxisomal membrane ABC transporter. ABCD2 (ALDR) displays
partial functional redundancy because when overexpressed, it is able to
correct the X-ALD biochemical phenotype. The ABCD2 promoter contains
a putative thyroid hormone-response element conserved in rodents and humans.
In this report, we demonstrate that the element is capable of binding retinoid
X receptor and 3,5,3'-tri-iodothyronine (T3) receptor
(TR
) as a heterodimer and mediating T3 responsiveness of
ABCD2 in its promoter context. After a T3 treatment, an
induction of the ABCD2 gene was observed in the liver of normal rats
but not that of TR
-/- mice. ABCD2 was not
induced in the brain of the T3-treated rats. However, we report for
the first time that induction of the ABCD2 redundant gene is feasible
in myelin-producing cells (differentiated CG4 oligodendrocytes). The induction
was specific for this cell type because it did not occur in astrocytes.
Furthermore, we observed T3 induction of ABCD2 in human
and mouse ABCD1-deficient fibroblasts, which was correlated with
normalization of the VLCFA
-oxidation. Finally, ABCD3
(PMP70), a close homolog of ABCD2, was also induced by
T3 in the liver of control rats, but not that of
TR
-/- mice, and in CG4 oligodendrocytes.
Address correspondence to: Dr. Maurice Bugaut, LBMC, Faculté des Sciences Gabriel, 6 Bd Gabriel, 21000 Dijon, France. E-mail: mbugaut{at}u-bourgogne.fr
This article has been cited by other articles:
![]() |
I. Weinhofer, M. Kunze, H. Rampler, A. L. Bookout, S. Forss-Petter, and J. Berger Liver X Receptor {alpha} Interferes with SREBP1c-mediated Abcd2 Expression: NOVEL CROSS-TALK IN GENE REGULATION J. Biol. Chem., December 16, 2005; 280(50): 41243 - 41251. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gondcaille, M. Depreter, S. Fourcade, M. R. Lecca, S. Leclercq, P. G.P. Martin, T. Pineau, F. Cadepond, M. ElEtr, N. Bertrand, et al. Phenylbutyrate up-regulates the adrenoleukodystrophy-related gene as a nonclassical peroxisome proliferator J. Cell Biol., April 11, 2005; 169(1): 93 - 104. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pujol, I. Ferrer, C. Camps, E. Metzger, C. Hindelang, N. Callizot, M. Ruiz, T. Pampols, M. Giros, and J. L. Mandel Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy Hum. Mol. Genet., December 1, 2004; 13(23): 2997 - 3006. [Abstract] [Full Text] [PDF] |
||||